{"id":13680,"date":"2024-06-10T13:01:46","date_gmt":"2024-06-10T20:01:46","guid":{"rendered":"https:\/\/depts.washington.edu\/diabetes\/?p=13680"},"modified":"2024-06-10T13:01:46","modified_gmt":"2024-06-10T20:01:46","slug":"sglp-1-gip-drug-tied-to-metabolic-improvements","status":"publish","type":"post","link":"https:\/\/depts.washington.edu\/diabetes\/sglp-1-gip-drug-tied-to-metabolic-improvements\/","title":{"rendered":"GLP-1\/GIP drug tied to metabolic improvements"},"content":{"rendered":"<section class=\"kc-elm kc-css-192333 kc_row\"><div class=\"kc-row-container  kc-container\"><div class=\"kc-wrap-columns\"><div class=\"kc-elm kc-css-757829 kc_col-sm-12 kc_column kc_col-sm-12\"><div class=\"kc-col-container\"><div class=\"kc-elm kc-css-671837 kc_text_block\">\n<p><span style=\"color: #999999; font-family: Helvetica, sans-serif;\"><span style=\"font-size: 15.3333px;\">A study in the <a href=\"https:\/\/newsletter.smartbrief.com\/redirect.action?link=https%3A%2F%2Fwww.nejm.org%2Fdoi%2Ffull%2F10.1056%2FNEJMoa2401943&amp;encoded=sdtGCehuiFDClgelCigmqPCicNmFdS\">New England Journal of Medicine<\/a> found that the Eli Lilly and Co. glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonist tirzepatide demonstrated a positive effect in patients with metabolic dysfunction-associated steatohepatitis and fibrosis. The diabetes and weight loss drug was also associated with improvements in markers of liver health.<\/span><\/span><\/p>\n<p><span style=\"color: #999999; font-family: Helvetica, sans-serif;\"><span style=\"font-size: 15.3333px;\">\u00a0Full Story: <a href=\"https:\/\/newsletter.smartbrief.com\/uyd\/editProfile.action?t1=80402162&amp;t2=https%3A%2F%2Fwww.medpagetoday.com%2Fmeetingcoverage%2Feasl%2F110557\">MedPage Today (free registration)<\/a> (6\/8)\u00a0\u00a0<\/span><\/span><\/p>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<\/div><\/div><\/div><\/div><\/div><\/section>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"link","meta":{"_mi_skip_tracking":false,"footnotes":""},"categories":[17],"tags":[],"class_list":["post-13680","post","type-post","status-publish","format-link","hentry","category-diabetes-related-news","post_format-post-format-link"],"_links":{"self":[{"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/posts\/13680","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/comments?post=13680"}],"version-history":[{"count":1,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/posts\/13680\/revisions"}],"predecessor-version":[{"id":13681,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/posts\/13680\/revisions\/13681"}],"wp:attachment":[{"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/media?parent=13680"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/categories?post=13680"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/tags?post=13680"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}